Stockreport

Epizyme up 25% premarket on removal of partial clinical hold on tazemetostat [Seeking Alpha]

Epizyme, Inc.  (EPZM) 
Last epizyme, inc. earnings: 2/24 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: epizyme.com
PDF Epizyme (NASDAQ: EPZM ) is up   premarket on modest volume in reaction to its announcement that the FDA has lifted the partial clinical hold on U.S. enrollment [Read more]